Histone deacetylase inhibitors increase glucocerebrosidase activity in Gaucher disease by modulation of molecular chaperones
Chunzhang Yang(National Institutes of Health), Zhengping Zhuang(National Institutes of Health)
Cited by 78
Related Papers
Somatic<i>HIF2A</i>Gain-of-Function Mutations in Paraganglioma with Polycythemia
|New England Journal of Medicine|2012|391
Vorinostat suppresses hypoxia signaling by modulating nuclear translocation of hypoxia inducible factor 1 alpha
|Oncotarget|2017|81
Celastrol increases glucocerebrosidase activity in Gaucher disease by modulating molecular chaperones
|Proceedings of the National Academy of Sciences|2013|45
Inhibition of PP2A with LB-100 Enhances Efficacy of CAR-T Cell Therapy Against Glioblastoma
|Cancers|2020|45
Mutant glucocerebrosidase in Gaucher disease recruits Hsp27 to the Hsp90 chaperone complex for proteasomal degradation
|Proceedings of the National Academy of Sciences|2015|28